2,330 research outputs found

    Global mapping of iron and titanium oxides in the lunar megaregolith and subsurface

    Get PDF
    [Abstract]: This paper reports mapping results obtained by remote sensing analysis of Iron and Titanium oxides in the megaregolith under the lunar Highlands regolith and in the subsurface under the Mare and South Pole Aitken basin regolith. FeO and TiO2 images were mosaicked from data extracted from the 1994 Clementine lunar orbiter mission from 600 N to 600 S, using the Lucey et al. technique (2000). These images then used to study the ejecta blanket for each of 2059 craters analysed using ISIS software (US Geological Survey). Average weight percentage values for each crater ejecta blanket were interpolated to derive underlying global Province Maps for FeO and TiO2. The Moon was divided into five (5) provinces as a balance of the needs of analysis requirements and simplicity. Division of global TiO2 weight percentages in the megaregolith /subsurface five provinces was matching the observed distribution of that at the surface. In contrast, division of lunar FeO into 5 Provinces reveals unexpectedly elevated iron concentrations (3.8 to 6.4%) in some areas of the Highland megaregolith. This Province of elevated iron oxide is termed “Highland II”

    Controlling the Use of Force: The Charter Regime and the Summit Agreements

    Get PDF

    Controlling the Use of Force: The Charter Regime and the Summit Agreements

    Get PDF

    A developmental and genetic classification for malformations of cortical development: update 2012.

    Get PDF
    Malformations of cerebral cortical development include a wide range of developmental disorders that are common causes of neurodevelopmental delay and epilepsy. In addition, study of these disorders contributes greatly to the understanding of normal brain development and its perturbations. The rapid recent evolution of molecular biology, genetics and imaging has resulted in an explosive increase in our knowledge of cerebral cortex development and in the number and types of malformations of cortical development that have been reported. These advances continue to modify our perception of these malformations. This review addresses recent changes in our perception of these disorders and proposes a modified classification based upon updates in our knowledge of cerebral cortical development

    Quantum orbital angular momentum of elliptically-symmetric light

    Get PDF
    We present a quantum mechanical analysis of the orbital angular momentum of a class of recently discovered elliptically-symmetric stable light fields --- the so-called Ince-Gauss modes. We study, in a fully quantum formalism, how the orbital angular momentum of these beams varies with their ellipticity and discover several compelling features, including: non-monotonic behavior, stable beams with real continuous (non-integer) orbital angular momenta, and orthogonal modes with the same orbital angular momenta. We explore, and explain in detail, the reasons for this behavior. These features may have application to quantum key distribution, atom trapping, and quantum informatics in general --- as the ellipticity opens up a new way of navigating the photonic Hilbert space.Comment: 9 Pages, 4 Figures, Comments Welcom

    How accurate is your sclerostin measurement?:Comparison between three commercially available sclerostin ELISA kits

    Get PDF
    Sclerostin, bone formation antagonist is in the spotlight as a potential biomarker for diseases presenting with associated bone disorders such as chronic kidney disease (CDK-MBD). Accurate measurement of sclerostin is therefore important. Several immunoassays are available to measure sclerostin in serum and plasma. We compared the performance of three commercial ELISA kits. We measured sclerostin concentrations in serum and EDTA plasma obtained from healthy young (18-26 years) human subjects using kits from Biomedica, TECOmedical and from R&D Systems. The circulating sclerostin concentrations were systematically higher when measured with the Biomedica assay (serum: 35.5 ± 1.1 pmol/L; EDTA: 39.4 ± 2.0 pmol/L; mean ± SD) as compared with TECOmedical (serum: 21.8 ± 0.7 pmol/L; EDTA: 27.2 ± 1.3 pmol/L) and R&D Systems (serum: 7.6 ± 0.3 pmol/L; EDTA: 30.9 ± 1.5 pmol/L). We found a good correlation between the assay for EDTA plasma (r > 0.6; p < 0.001) while in serum, only measurements obtained using TECOmedical and R&D Systems assays correlated significantly (r = 0.78; p < 0.001). There was no correlation between matrices results when using the Biomedica kit (r = 0.20). The variability in values generated from Biomedica, R&D Systems and TECOmedical assays raises questions regarding the accuracy and specificity of the assays. Direct comparison of studies using different kits is not possible and great care should be given to measurement of sclerostin, with traceability of reagents. Standardization with appropriate material is required before different sclerostin assays can be introduced in clinical practice
    corecore